U.S. Life Sciences Stock News

Morgan Stanley stock has surged over the past three years, yet current valuation checks suggest the share price now sits close to its intrinsic value rather than standing out as either a clear bargain or an obvious excess. Over the past three years, Morgan Stanley has returned roughly 160%, which puts extra focus on whether recent gains are now largely reflected in the price. The expansion into crypto and AI related products and financing, including new Ether and Solana exchange traded...

Recently, Argan, Inc. saw heightened options activity, with the Dec. 18, 2026 $240 call emerging as one of the most volatile contracts, while analysts assigned the company a Zacks Rank #1 (Strong Buy) and raised earnings estimates for the current quarter. This combination of active options trading and upgraded analyst expectations signals elevated investor focus on Argan’s near‑term operating outlook and earnings power. Next, we’ll examine how this spike in options activity and analyst...

Federated Hermes stock barely budged on the earnings news, ticking up less than 1%, even though the quarter delivered record assets and a solid profit print. Investors who came in expecting just another money market story instead saw basic earnings per share at about US$1.45 and total revenue around US$503 million, both supported by higher assets under management. The real headline is simple. This was a profitability and scale quarter, not a dramatic rerating one. The share price reaction...

Caledonia Mining stock has delivered an 86.6% gain over the past five years, yet the recent share price slide this year raises the question of whether the current level still looks cheap based on the broader valuation checks. The 86.6% return over five years points to a stock that has already rewarded long term holders, so new investors need to consider how much value is still left on the table. Fresh drilling success at the Blanket Mine, including the new K Pits target and planned heap...

T. Rowe Price Group stock has delivered a decline of about 35.0% over the past 5 years, yet current valuation checks and the intrinsic value estimate from the Excess Returns model both indicate the shares may be trading at a discount to what the business could be worth. The roughly 35.0% share price decline over 5 years means long term holders have seen meaningful capital losses despite more recent gains. Investor focus on earnings prospects for smaller companies, highlighted by interest in...

UMH Properties stock sits at the center of a valuation split, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to a sizeable potential discount, while traditional market multiples suggest the shares already trade at a premium. The stock has also delivered mixed long term returns, which adds another layer to the debate about what investors are really paying for. Over the past 5 years the share price is down about 20%, which means long term holders have not...

LeMaitre Vascular (LMAT) has drawn investor attention after recent share price moves, with the stock closing at $101.32 on 29 July 2026. The company operates in the medical devices segment focused on vascular surgery. See our latest analysis for LeMaitre Vascular. Recent trading reflects that momentum in LeMaitre Vascular has cooled slightly in the very short term, with a 1 day share price return that declined 0.85%, following a strong year to date share price return of 26.38% and a 5 year...

Life Time Group Holdings walked into this earnings print with its stock already on a strong run, up roughly 69% over the past three months and another 2% on the day around the release. For a fitness and wellness operator often framed as a long term growth story, the headline this quarter is straightforward. Revenue reached about US$866m and net income came in just over US$100m, while adjusted EBITDA margin moved into the high 20s. The market reaction so far suggests investors are treating...

Coinbase Global is waking up to a harsh verdict. The stock dropped about 11% to roughly US$146 after investors reacted to fresh quarterly numbers that showed another loss and softer revenue. The short term message is blunt. Crypto volumes and fee income are not doing enough right now to offset the cost base. The long term question is very different. Coinbase is still being valued at more than 6x sales while trailing twelve month earnings sit in the red. The key takeaway from this earnings...

Eversource Energy stock has delivered a 22.2% return over the past three years, yet its current valuation sends mixed signals, with the Dividend Discount Model (DDM) implying the shares trade at a premium while earnings based multiples point to better value. The 22.2% three year return suggests Eversource Energy has already rewarded patient shareholders, which raises the bar for any new upside from here. The refocus on regulated electric and natural gas delivery after the Aquarion Water sale...

Curtiss-Wright (CW) heads into its June 2026 quarter earnings with expectations for growth in earnings per share, after analysts raised their consensus forecasts over the past month. See our latest analysis for Curtiss-Wright. The recent pullback, with a 7 day share price return of 3.49% and a 30 day share price return of 4.46%, contrasts with Curtiss-Wright’s stronger year to date share price return of 26.49% and a 5 year total shareholder return above 5x. This suggests longer term momentum...

The GEO Group, Inc. recently announced a five-year support services contract with U.S. Immigration and Customs Enforcement for exclusive use of its 1,320-bed Rivers Facility in Winton, North Carolina, which is expected to generate about US$80,000,000 in annual revenue in its first full year. The agreement deepens GEO’s role in federal immigration processing by bundling security, maintenance, food service, recreation, medical care, and access to legal counsel into a single, long-term...

Capital One Financial has delivered a 92.4% share price gain over the past three years, yet its current checks still point to a stock that screens as undervalued rather than fully priced in. Both the Excess Returns intrinsic value estimate and market multiples lean in the same direction, which puts more focus on whether that apparent discount is justified by the risks now in view. Over the past three years the stock is up 92.4%. This means anyone looking at Capital One Financial today is...

In July 2026, National Bank Holdings Corporation reported second-quarter and first-half 2026 results, with net interest income rising to US$109.29 million for the quarter and US$218.09 million for the half-year, while net income and earnings per share from continuing operations declined compared with the prior year periods. Alongside these mixed earnings, the company also completed a tranche of its January 2026 share repurchase program, buying back 664,579 shares for US$27.21 million in...

Regeneron Pharmaceuticals stock jumped about 3% to around US$763 after its latest report, a clear sign traders liked what they saw in the headline numbers. The bigger story sits in the profit engine behind that move. Quarterly basic earnings per share came in at US$12.62 on revenue of US$4.29b, while trailing net margin stands at 27.9%, compared with 31.4% a year earlier. In the short term, the market is cheering the earnings print. Over a longer horizon, investors now have to weigh that...

Cigna Group stock was essentially flat over the past month going into the earnings release, then slipped almost 3% to about US$279 as investors digested the latest numbers. The market is reacting to headlines, but the earnings story centers on profit power. Adjusted EPS guidance has been lifted to at least US$30.45 for 2026, while quarterly adjusted EPS came in at US$7.78 on US$71.7 billion of revenue. That combination of a sliding share price and firmer earnings guidance sets up a clear...

Belden stock jumped about 6% today to roughly US$124 after investors reacted to a Q2 earnings beat that leaned heavily on profits rather than just top line growth. Adjusted earnings per share reached US$2.34 on US$750.2m of revenue, which put fresh attention on how much profit Belden can squeeze from each networking and industrial automation dollar. The short term move is eye catching. The bigger story is the long term profit engine that investors now have to weigh against a more leveraged...

Iovance Biotherapeutics stock has delivered a strong rebound over the past year, yet longer term holders are still facing steep losses, so the current valuation attracts close attention. The share price now sits against a backdrop where the broader checks lean cheap. This raises the question of whether the market is still underpricing the company or simply adjusting after a difficult few years. Over 5 years, Iovance Biotherapeutics is down 82.7%, which means many long term investors are...

In July 2026, Gentherm Incorporated reported second-quarter 2026 net income of US$4.42 million and diluted EPS of US$0.14 from continuing operations, alongside the completion of a prior 1,021,070‑share buyback for US$39.9 million and the authorization of a new share repurchase program of up to US$400 million through July 2029. This combination of stronger profitability and a larger, freshly approved repurchase authorization signals management’s confidence in the business while potentially...

Korn Ferry recently highlighted its role in helping companies turn staffing into a core strategic function, supported by digital innovation and AI, while also reporting its fifth consecutive quarter of top-line growth across multiple service lines. This combination of workforce-transformation positioning and consistent revenue momentum appears to be reinforcing investor confidence in Korn Ferry’s broader business model. Next, we’ll examine how Korn Ferry’s AI-enabled workforce transformation...

Crocs stock came into this print with a mixed backdrop for investors. The share price was up strongly over the past 3 months, yet the 7 day move was slightly negative. The instant verdict after the Q2 release was clear. The stock climbed about 3.5% to around US$128. The headline was not just another solid quarter. Crocs posted about US$1.2b in revenue and adjusted earnings per share of US$4.55, and management lifted both full year sales and earnings guidance. For a company often treated as a...

BGC Group went into this earnings print with the stock roughly flat over the past month and down slightly in the last week, then slipped another 1.4% to about US$11.50 after the numbers hit. That reaction sits awkwardly against a quarter built around margin strength rather than headline revenue. The real story is profit quality. Adjusted pretax earnings reached US$192.9m and adjusted earnings before interest, tax, depreciation and amortisation came in at US$228.7m, both higher than a year...

Nomad Foods (NOMD) drew fresh attention after refinancing its capital structure through a €800 million senior secured notes offering due 2033 and increasing revolving credit facility commitments by €105 million, with proceeds applied to repay 2028 notes. See our latest analysis for Nomad Foods. Against this refinancing backdrop, Nomad Foods’ share price shows mixed momentum, with a 90 day share price return of 25% but a 1 year total shareholder return that declined 25.84%. This suggests...

Piper Sandler Companies stock barely flinched after earnings, edging down about 0.5% to US$75.80, even though the investment bank just posted another quarter of solid advisory and banking income. The market reaction was muted, but the headline is clear. Q2 adjusted net revenues reached about US$491m and adjusted earnings per share were US$1.04, with operating margin near 22%. For a capital markets firm, that level of profitability reflects more than a single quarter. The key question is how...